Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nisha A

Showing results (241-250 of 255) with videos related to

Pageof 26
Sort By:
The Journal of Cardiovascular Nursing|October 19, 2023
Use of Human-Centered Design Methodology to Develop a Digital Toolkit to Optimize Heart Failure Guideline-Directed Medical TherapyErin M Spaulding, Nino Isakadze, Nancy Molello, et al.
Journal of the American Heart Association|July 12, 2021
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVALNisha A Gilotra, Salpy V Pamboukian, Maria Mountis, et al.
BMJ Open Quality|January 12, 2025
Implementation of patient-reported outcome dashboards within the electronic health record to support shared decision-making in serious chronic illnessLaura M Perry, Nisha A Mohindra, Ava Coughlin, et al.
Journal of Cardiac Failure|December 7, 2019
Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope DependenceInna Tchoukina, Keyur B Shah, Jennifer T Thibodeau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve <i>EGFR</i>-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial)Xiuning Le, Jyoti D Patel, Elaine Shum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Management of Immunotherapy-Related Toxicities, Version 1.2019John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 7, 2022
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in OncologyJohn A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Transplantation|May 21, 2024
Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert OpinionKymberly D Watt, Stacey Rolak, David P Foley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Pageof 26

Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
The Journal of Cardiovascular Nursing|October 19, 2023
Use of Human-Centered Design Methodology to Develop a Digital Toolkit to Optimize Heart Failure Guideline-Directed Medical TherapyErin M Spaulding, Nino Isakadze, Nancy Molello, et al.
Journal of the American Heart Association|July 12, 2021
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVALNisha A Gilotra, Salpy V Pamboukian, Maria Mountis, et al.
BMJ Open Quality|January 12, 2025
Implementation of patient-reported outcome dashboards within the electronic health record to support shared decision-making in serious chronic illnessLaura M Perry, Nisha A Mohindra, Ava Coughlin, et al.
Journal of Cardiac Failure|December 7, 2019
Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope DependenceInna Tchoukina, Keyur B Shah, Jennifer T Thibodeau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve <i>EGFR</i>-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial)Xiuning Le, Jyoti D Patel, Elaine Shum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Management of Immunotherapy-Related Toxicities, Version 1.2019John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 7, 2022
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in OncologyJohn A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Transplantation|May 21, 2024
Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert OpinionKymberly D Watt, Stacey Rolak, David P Foley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Pageof 26